Creative Planning’s PAVmed PAVM Stock Holding History

Creative Planning’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25	Closed	-$3.34K	–	2998
2023 Q3	$3.34K	Sell	25 -1	-4%	-$155	﹤0.01%	2766
2023 Q2	$4.82K	Buy	26 +2	+8%	+$400	﹤0.01%	2572
2023 Q1	$3.96K	Sell	24 -2	-8%	-$421	﹤0.01%	2498
2022 Q4	$5.67K	Hold	26	–	–	﹤0.01%	2386
2022 Q3	$10K	Buy	+26	New	+$14.7K	﹤0.01%	2232
2021 Q2	–	Sell	-351	Closed	-$702K	–	2448
2021 Q1	$702K	Buy	351 +140	+66%	+$211K	﹤0.01%	1225
2020 Q4	$201K	Buy	+211	New	+$180K	﹤0.01%	1903

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Creative Planning's PAVM Position: Q4 2023 in Review

Creative Planning sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 25 shares — an estimated $3.34K sold.

Creative Planning first reported a position in PAVM in Q4 2020 and held it in 7 quarters. The position peaked at $702K in Q1 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

Creative Planning reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
Creative Planning sold 25 PAVmed shares in Q4 2023, an estimated $3.34K.
Creative Planning first reported a position in PAVmed in Q4 2020 and held it in 7 quarters.
Creative Planning's PAVmed position peaked at $702K in Q1 2021.
23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Creative Planning's 13F filing for Q4 2023, filed 14 Feb 2024.